The present invention relates to novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamide derivatives of the formula
stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonists. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.
本发明涉及新型取代的N-甲基-N-(4-(
哌啶-1-基)-2-(芳基)丁基)苯甲酰胺衍
生物,其立体异构体和药学上可接受的盐,其可作为
组织胺受体拮抗剂和速激肽受体拮抗剂。这些拮抗剂可用于过敏性鼻炎的治疗,包括季节性鼻炎和鼻窦炎;炎症性肠病,包括克罗恩病和溃疡性结肠炎;哮喘;支气管炎;以及呕吐。